CG
NVO

Castellan Group’s Novo Nordisk NVO Stock Holding History

Castellan Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-29,276
Closed -$3.49M – 67
2024
Q3 		$3.49M Sell
29,276
-13,195
-31% -$1.76M 1.47% 30
2024
Q2 		$6.06M Buy
42,471
+2,162
+5% +$286K 2.89% 8
2024
Q1 		$5.18M Sell
40,309
-3,598
-8% -$428K 2.65% 14
2023
Q4 		$4.54M Buy
43,907
+3,032
+7% +$300K 2.82% 6
2023
Q3 		$3.72M Sell
40,875
-3,873
-9% -$341K 2.61% 7
2023
Q2 		$3.62M Sell
44,748
-6,782
-13% -$554K 2.31% 11
2023
Q1 		$4.1M Sell
51,530
-4,520
-8% -$321K 2.8% 7
2022
Q4 		$3.79M Sell
56,050
-610
-1% -$35.8K 2.64% 8
2022
Q3 		$2.82M Sell
56,660
-4,570
-7% -$245K 2.19% 19
2022
Q2 		$3.41M Sell
61,230
-2,620
-4% -$145K 2.7% 8
2022
Q1 		$3.54M Buy
63,850
+6,610
+12% +$339K 2.46% 9
2021
Q4 		$3.21M Buy
57,240
+13,400
+31% +$726K 2.22% 7
2021
Q3 		$2.1M Buy
+43,840
New +$2.12M 1.08% 31

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Castellan Group's NVO Position: Q4 2024 in Review

Castellan Group sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 29,276 shares — an estimated $3.49M sold.

Castellan Group first reported a position in NVO in Q3 2021 and held it in 13 quarters. The position peaked at $6.06M in Q2 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Castellan Group reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Castellan Group sold 29,276 Novo Nordisk shares in Q4 2024, an estimated $3.49M.
  • Castellan Group first reported a position in Novo Nordisk in Q3 2021 and held it in 13 quarters.
  • Castellan Group's Novo Nordisk position peaked at $6.06M in Q2 2024.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Castellan Group's 13F filing for Q4 2024, filed 29 Jan 2025.